文献类型：期刊文献

中文题名：全球化背景下跨国药企的权力运作

英文题名：The Power Operation of Multinational Pharmaceutical Companies:Sociological Analysis

作者：萧易忻[1];徐永祥[2]

机构：[1]华东理工大学应用社会学研究所;[2]华东理工大学社会与公共管理学院

年份：2014

期号：12

起止页码：60

中文期刊名：社会科学

外文期刊名：Journal of Social Sciences

收录：国家哲学社会科学学术期刊数据库;北大核心:【北大核心2011】；社科基金资助期刊;CSSCI:【CSSCI2014_2016】；

语种：中文

中文关键词：跨国药企;制度策略;政商策略;营销策略;新自由主义

外文关键词：Multinational Pharmaceutical Companies ; Institutional Strategies ; Politic-Commercial Strategies ; Marketing Strategies ; Neo-Liberalism

摘要：近年来跨国药企在中国行贿事件陆续曝光,揭示了其在发展中国家获取高额利润部分依靠权力运作的事实。跨国药企主要是透过制度策略、政商策略与营销策略进行权力运作以打通商业关节。在制度方面,药企游说母国在国际上推动有利于跨国资本流动的国际规范与有利于他们的专利权制度;政商策略表现在跨国企商常与发展中国家政府共谋,并与母国审查人员有利益关联,还促使政府加快药品核准上市的流程等;营销策略则包含扩大药物使用范围及透过行贿控制高药价等,三种策略皆镶嵌在新自由主义全球化的结构力量之中。
Recently a couple of multinational pharmaceutical companies （MPC） have been exposed being involved in bribing in China, which enclosed a fact that apart from their products＇ quality, MPCs heavily rely on power operating to guarantee their high profits. However, in China there has been a lack of sociological research on their power maneuvering. It is this research＇s aim to fill in the gap, and it suggests MPCs have made their way through three types of strategies regarding institution, political- commercial relationship and marketing, and all three strategies are embedded in the structure of neoliberal globalization. Institutionally, MPCs lobby their home countries to push forward policies and international norms in favor of cross-border capital flows, and take sides with the patent system to protect private property system in the international community. Politic-commercial relationship-wise, MPCs build up complicity with the governments of developing countries, develop the medical examiners of home countries their stakeholders, and prompt the governments of their own to speed up the listing of approved drugs processes. Marketing strategies include seven ways of doing ranging from expanding the scope of drug use to controlling high prices of medicine through bribery.